Tag: CORO
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin
41.6 Percent of Adults Have Serology Indicative of Past COVID-19 Infection
25.5 percent of those whose serology indicated past infection reported not having been vaccinated, with higher rates seen in young, Black adults
Feds Urge Vaccination as ‘Tripledemic’ Hits More Americans
Vaccination will be key to keeping patients healthy through the winter holidays
Pfizer Asks FDA to Approve Tweaked COVID-19 Booster as Third Shot for Under 5s
Though children aged 5 years and older and adults need only two doses to complete a primary series, younger children need three doses
FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
Immunocompromised patients can still receive convalescent plasma
Dynamically Updating Models Can Improve Prediction of COVID-19 Survival
Drift in model calibration performance was detected immediately, with minor fluctuations in discrimination
Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization
Posthospitalization prevalence of residual lung abnormalities estimated at 11.7 percent in sensitivity analyses
PTSD, Psychiatric Disorders Tied to Higher Risk for Severe COVID-19 Outcomes
Findings seen even when accounting for sociodemographic factors, comorbidities, and smoking
Temporal Improvement Seen in Standard of Care for Hospitalized COVID-19 Patients
Outcomes improved from Adaptive COVID-19 Treatment Trial-2 to ACTT-3, although potential explanatory factors were similar
Overactive Bladder Common in Postacute COVID-19 Syndrome
COVID-19 may lead to new or worsening urinary symptoms in men and women
